Harbour Investments, Inc. Vbi Vaccines Inc Transaction History

Harbour Investments, Inc.

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$0.66 - $1.81 $660 - $1,810	-1,000 Closed	0 $0
Q4 2021 Feb 16, 2022	SELL	$2.21 - $3.22 $11 - $16	-5 Reduced 0.5%	1,000 $2,000
Q3 2021 Nov 15, 2021	BUY	$2.8 - $3.72 $2 - $3	1 Added 0.1%	1,005 $3,000
Q1 2021 Aug 17, 2021	BUY	$2.91 - $4.32 $2,907 - $4,315	999 Added 19980.0%	1,004 $3,000
Q1 2021 May 12, 2021	BUY	$2.91 - $4.32 $14 - $21	5 New	5 $0

688K

Ticker VBIV
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 258,256,992
Market Cap $5.17M
Description
VBI Vaccines Inc., a biopharmaceutical company, develops and sells vaccines for the treatment of infectious diseases and immuno-oncology. The company offers Sci-B-Vac, a prophylactic hepatitis B (HBV) vaccine. It also engages in the development of VBI-2601 (BRII-179), an immunotherapeutic candidate for the treatment of chronic HBV infection. The...

Get notified when there are updates to the investment portfolio of Harbour Investments, Inc., based on Form 13F filings with the SEC.

Stay updated on Harbour Investments, Inc. with notifications on news.